组蛋白修饰介导的TNFAIP3下调导致系统性红斑狼疮T细胞功能障碍
该研究探讨系统性红斑狼疮(SLE)患者CD4+ T细胞中TNFAIP3的表达及其表观遗传调控机制。发现SLE患者CD4+ T细胞中TNFAIP3 mRNA显著下调,与基因启动子区H3K4me3减少相关;功能实验表明TNFAIP3下调可导致IFN-γ和IL-17过度产生,参与SLE发病。
要点
- SLE患者CD4+ T细胞中TNFAIP3 mRNA显著下调,与启动子区H3K4me3减少相关。
- 敲低正常CD4+ T细胞TNFAIP3可增加IFN-γ和IL-17表达,但不影响IL-2、IL-4和IL-5。
- 过表达SLE患者CD4+ T细胞TNFAIP3可抑制IFN-γ和IL-17产生。
核心结论
- SLE患者CD4+ T细胞中TNFAIP3下调可能由组蛋白H3K4去甲基化导致启动子区H3K4me3减少所调控。
- TNFAIP3失调可能通过过度产生炎症细胞因子IFN-γ和IL-17参与SLE发病。
- TNFAIP3可能成为SLE临床治疗的有希望的靶点。
研究设计与样本
- 研究比较SLE患者与正常对照(NCs)CD4+ T细胞中TNFAIP3的表达及表观遗传调控,采用RT-quantitative PCR、western blot和染色质免疫沉淀。
- 通过敲低或过表达TNFAIP3在SLE患者和正常对照CD4+ T细胞中评估其功能效应。
主要发现
- 与正常对照相比,SLE患者CD4+ T细胞中TNFAIP3 mRNA显著下调。
- TNFAIP3表达降低与基因启动子区域H3K4me3减少相关。
- 使用小干扰RNA功能性阻断正常CD4+ T细胞中TNFAIP3可增加IFN-γ和IL-17表达,但不影响IL-2、IL-4和IL-5。
- 在SLE患者CD4+ T细胞中过表达TNFAIP3导致IFN-γ和IL-17产生受抑制。
临床怎么用
- TNFAIP3可能作为SLE临床治疗的潜在靶点。
- SLE患者CD4+ T细胞中TNFAIP3下调及H3K4me3减少可能成为评估疾病机制的线索。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: TNF-α-induced protein 3 ( TNFAIP3 ) is one of the major SLE susceptibility genes involved in the regulation of inflammatory responses through modulation of the nuclear factor-κB (NF-κB) pathway. We aim to assess TNFAIP3 expression in CD4 + T cells and the molecular mechanism underlying TNFAIP3 regulation in the pathogenesis of SLE. METHODS: The expression and epigenetic regulation of TNFAIP3 in CD4 + T cells from SLE patients and normal controls (NCs) were investigated by RT-quantitative PCR, western blot and chromatin immunoprecipitation. The functional effect of TNFAIP3 was further evaluated by knockdown or overproduction of TNFAIP3 in CD4 + T cells from SLE patients and NCs. RESULTS: TNFAIP3 mRNA was significantly downregulated in the CD4 + T cells of SLE patients compared with NCs. The reduced expression of TNFAIP3 was associated with the reduction of H3K4me3 in the gene promoter region. Functional blockage of TNFAIP3 in normal CD4 + T cells using small interfering RNA increased the expression of IFN-γ and IL-17, but not IL-2, IL-4 and IL-5. Nevertheless, overexpression of TNFAIP3 in CD4 + T cells from SLE patients resulted in the suppression of IFN-γ and IL-17 production. CONCLUSION: The downregulation of TNFAIP3 in CD4 + T cells of SLE was potentially regulated by demethylation of histone H3K4, which led to a decreased amount of H3K4me3 in the promoter of the TNFAIP3 gene. The dysregulation of TNFAIP3 in CD4 + T cells may contribute to the pathogenesis of SLE by overproduction of inflammatory cytokine IFN-γ and IL-17. TNFAIP3 may serve as a promising target for the treatment of SLE in clinical practice.
引用
- Zhao H, Wang L, Luo H, et al. TNFAIP3 downregulation mediated by histone modification contributes to T-cell dysfunction in systemic lupus erythematosus. Rheumatology (Oxford). 2017. PMID: 28158872. doi:10.1093/rheumatology/kew508
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。